Development of solid self-Emulsifying drug delivery system (SEDDS) I: Use of poloxamer 188 as both solidifying and emulsifying agent for lipids

Pharmaceutical Research

Volumn 29, Issue 10, 2012, Pages 2817-2832

  Shah, Ankita V ^a   Serajuddin, Abu T M ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Drug dispersion; Microemulsion; Poloxamer 188; Self emulsifying drug delivery systems; Solid microemulsion preconcentrate

Indexed keywords

CREMOPHOR; FATTY ACID; FENOFIBRATE; GLYCEROL; GLYCEROL OLEATE; GLYCERYL CAPRYLOCAPRATE; GLYCERYL MONOLINOLEATE; LABRASOL; LIPID; MACROGOL 8000; OCTANOIN; POLOXAMER; PROBUCOL; PROPYLENE GLYCOL; PROPYLENE GLYCOL MONOCAPRYLATE; PROPYLENE GLYCOL MONOLAURATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; EMULSION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; MICROSCOPY; PARTICLE SIZE; POLARIZATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SEPARATION TECHNIQUE; SOLID; SOLID EMULSIFYING DRUG DELIVERY SYSTEM; X RAY POWDER DIFFRACTION;

DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; EMULSIONS; FATTY ACIDS; FENOFIBRATE; GLYCEROL; PARTICLE SIZE; POLOXAMER; POLYETHYLENE GLYCOLS; PROBUCOL; SOLUBILITY; WATER;

EID: 84866734190     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0704-x     Document Type: Article

References (56)

1. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1-3):3-26.
2. Hörter D, Dressman J. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46(1-3):75-87.
3. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 1997;25(1):103-28.
4. Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673-91.
5. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs: drug delivery and drug efficacy. Biomed Pharmacother. 2004;58 (3):173-82.
6. Strickly RG. Currently marketed oral lipid-based dosage forms: drug products and excipients. In: Hauss D, editor. Lipid-based formulations for oral drug delivery: enhancing bioavailability of poorly water-soluble drugs. New York: Informa Healthcare; 2007. p. 1-31.
7. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Selfemulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994;106(1):15-23.
8. Bachynsky MO, Shah NH, Patel CI, Malick AW. Factors affecting the efficiency of a self-emulsifying oral delivery system. Drug Dev Ind Pharm. 1997;23(8):809-16.
9. Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997;25(1):47-58.
10. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci. 2000;11:S93-8.
11. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29 (3-4):278-87.
12. Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007;59(7):667-76.
13. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60(6):734-46.
14. Vasanthavada M, Serajuddin ATM. Lipid-based self-emulsifying solid dispersions. In: Hauss D, editor. Lipid-based formulations for oral drug delivery: enhancing bioavailability of poorly water soluble drugs. New York: Informa Healthcare; 2007. p. 149-84.
15. Savolainen M, Khoo C, Glad H, Dahlqvist C, Juppo AM. Evaluation of controlled-release polar lipid microparticles. Int J Pharm. 2002;244(1-2):151- 61.
16. Desai D, Kothari S, Chen W, Wang J, Huang M, Sharma L. Fatty acid and water-soluble polymer-based controlled release drug delivery system. J Pharm Sci. 2011;100(5):1900-12.
17. Aoshima H, Miyagisnima A, Nozawa Y, Sadzuka Y, Sonobe T. Glycerin fatty acid esters as a new lubricant of tablets. Int J Pharm. 2005;293(1-2):25-34.
18. Tang B, Cheng G, Gu JC, Xu CH. Development of solid selfemulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today. 2008;13(13-14):606-12.
19. Cole ET, Cadé D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60(6):747-56.
20. Ito Y, Kusawake T, Ishida M, Tawa R, Shibata N, Takada K. Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release. 2005;105(1-2):23-31.
21. Patil P, Paradkar A. Porous polystyrene beads as carriers for selfemulsifying system containing loratadine. AAPS PharmSciTech. 2006;7(1):E1-7.
22. Abdalla A, Klein S, Mäder K. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci. 2008;35(5):457-64.
23. Agarwal V, Siddiqui A, Ali H, Nazzal S. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). Int J Pharm. 2009;366(1-2):44-52.
24. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 2010;383(1-2):1-6.
25. Tan A, Davey AK, Prestidge CA. Silica-Lipid Hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib. Pharm Res. 2011;28(9):2273-87.
26. Hansen T, Holm P, Schultz K. Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid. Int J Pharm. 2004;287(1-2):55-66.
27. Dollo G, Le Corre P, Guérin A, Chevanne F, Burgot JL, Leverge R. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur J Pharm Sci. 2003;19 (4):273-80.
28. Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm. 2008;70(2):439-44.
29. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002;240(1-2):103-14.
30. Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters. Int J Pharm. 2006;315(1-2):110-21.
31. Nazzal S, Zaghloul AA, Khan MA. Effect of Extragranular Microcrystalline Cellulose on compaction, surface roughness, and in vitro dissolution of a self-nanoemulsified solid dosage forms of ubiquinone. Pharm Tech. 2002;26:86-98.
32. Li P, Hynes SR, Haefele TF, Pudipeddi M, Royce AE, Serajuddin ATM. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. J Pharm Sci. 2009;98(5):1750-64.
33. Margulis-Goshen K, Kamyshny A, Magdassi S. Applications of surfactants in pharmaceutical dosage forms. In: Zoller U, editor. Handbook of detergents, part E: applications. Boca Raton: CRC; 2008. p. 455-66.
34. Vippagunta SR, Maul KA, Tallavajhala S, Grant DJW. Solidstate characterization of nifedipine solid dispersions. Int J Pharm. 2002;236(1-2):111-23.
35. Chen Y, Zhang GGZ, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm. 2004;286(1-2):69-80.
36. Brüsewitz C, Schendler A, Funke A, Wagner T, Lipp R. Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. Int J Pharm. 2007;329(1-2):173-81.
37. Fernandez-Tarrio M, Yañez F, Immesoete K, Alvarez-Lorenzo C, Concheiro A. Pluronic and Tetronic copolymers with polyglycolyzed oils as self-emulsifying drug delivery systems. AAPS PharmSciTech. 2008;9(2):471-9.
38. Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients. London: Pharmaceutical; 2006. p. 447-50.
39. Cannon JB, Long MA. Emulsions, microemulsions, and lipidbased drug delivery systems for drug solubilization and delivery-Part II: Oral applications. In: Liu R, editor. Water-insoluble drug formulation. Boca Raton: CRC; 2008. p. 227-53.
40. Prajapati HN, Dalrymple DM, Serajuddin ATM. A comparative evaluation of mono, di and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharm Res. 2012;29(1):285-305.
41. Amidon GL, Lennernäs H, Shah VP, Crison Jr. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-20.
42. Morris KR, Knipp GT, Serajuddin ATM. Structural properties of polyethylene glycol -polysorbate 80 mixture, a solid dispersion vehicle. J Pharm Sci. 1992;81(12):1185-8.
43. Law TK, Whateley TL, Florence AT. Some chemically modified poloxamer hydrogels: preparation, morphology and swelling properties. Int J Pharm. 1984;21(3):277-87.
44. Ginés JM, Arias MJ, Moyano JR, Sánchez-Soto PJ. Thermal investigation of crystallization of polyethylene glycols in solid dispersions containing oxazepam. Int J Pharm. 1996;143(2):247-53.
45. Hosier IL, Bassett DC, Vaughan AS. Spherulitic growth and cellulation in dilute blends of monodisperse long n-alkanes. Macromolecules. 2000;33:8781-90.
46. Gránásy L, Pusztai T, Tegze G, Warren JA, Douglas JF. Growth and form of spherulites. Phys Rev E. 2005;72(1):011605.
47. Billmeyer Jr. FW, Ceil PH, van der Weg KR. Growth and observation of spherulites in polyethylene: a high polymer demonstration. J Chem Educ. 1960;37(9):460-1.
48. Mohsin K, Long MA, Pouton CW. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci. 2009;98(10):3582-95.
49. Yagi N, Terashima Y, Kenmotsu H, Sekikawa H, Takada M. Dissolution behavior of probucol from solid dispersion systems of probucol- polyvinylpyrrolidone. Chem Pharm Bull. 1996;44 (1):241-4.
50. Nielsen FS, Gibault E, Ljusberg-Wahren H, Arleth L, Pedersen JS, Müllertz A. Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J Pharm Sci. 2007;96 (4):876-92.
51. Rane SS, Anderson BD. What determines drug solubility in lipid vehicles: is it predictable? Adv Drug Deliv Rev. 2008;60(6):638-56.
52. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212 (2):233-46.
53. Craig D. Polyethyelene glycols and drug release. Drug Dev Ind Pharm. 1990;16(17):2501-26.
54. Craig DQM. A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glass transition behaviour of polyethylene glycols. Thermochim Acta. 1995;248:189-203.
55. Mahlin D, Ridell A, Frenning G, Engström S. Solid-state characterization of PEG 4000/monoolein mixtures. Macromolecules. 2004;37(7):2665-7.
56. Tejwani RW, Joshi HN, Varia SA, Serajuddin A. Study of phase behavior of poly (ethylene glycol)-polysorbate 80 and poly (ethylene glycol)-polysorbate 80-water mixtures. J Pharm Sci. 2000;89(7):946-50.